We are live on ! Find out more

Philips

PHG

Market cap $24.5B

25.08 USD

+0.49

1.99%

At close Updated Sep 14, 4:00 PM EDT

Pre-market

After hours

25.08

0.00

0%

1 day

1.99%

5 days

-2.37%

1 month

-8.1%

3 months

-6.03%

6 months

-7.93%

Year to date

-3.91%

1 year

-7.66%

5 years

-35.28%

10 years

18.64%

About: Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Employees: 63,670

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 26.9%

Neutral 65.4%

Negative 7.7%

Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, this month launched the Philips Lumea IPL 9900 Pro, transforming at-home hair removal into a personalized and rewarding self-care routine. Philips Lumea IPL 9900 Pro is the first at-home IPL with audio feedback and motion guidance that talks to users2, helping give them greater confidence in effective treatment. As the world's no. 1 IPL brand3, Philips brings 25 years of IPL research a.

Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment

Zacks Investment Research

Philips Expands Women's Health Ultrasound Portfolio With New Transducer

PHG broadens women's health ultrasound portfolio with the eV14-2v, offering enhanced imaging, a lighter design and remote collaboration.

Philips Expands Women's Health Ultrasound Portfolio With New Transducer

Zacks Investment Research

Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC

PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.

Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC

Philips advances women's health ultrasound with new single-transducer solution

September 3, 2026 FDA 510(k) cleared and CE marked, the eV14-2v combines exceptional image quality and broad clinical capabilities in one lightweight transducer, helping streamline exams, support diagnostic confidence, and improve the patient experience Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the eV14-2v transvaginal transducer, expanding its obstetrics and gynecology ultrasound portfolio. FDA 510(k) cleared and CE marked, the eV14-2v is designed to support a broad range of gynecology and early obstetrics exams by combining image quality and broad clinical capabilities in a single lightweight transducer.

Philips advances women's health ultrasound with new single-transducer solution

Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration

August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imrico r' s exclusive portfolio of systems and consumables for MR-guided cardiac interventions. Amsterdam, the Netherlands – August 27, 2026: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR.

Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration

Philips selected for ARPA-H program to advance AI-enabled robotic stroke care

August 26, 2026 Philips receives up to US$33.7 million award from ARPA-H to expand access to AI-enabled robotic stroke care, supporting the program's goal of expanding access to specialized interventions Philips will collaborate with Johns Hopkins University and Boston University to develop technologies for remote and increasingly automated endovascular procedures Building on Philips' leadership in image-guided therapy and the Azurion platform, the work lays the foundation for a future interventional suite that integrates robotics, AI-enabled automation and smart devices into a single clinical workflow Cambridge, MA, USA and Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received an up to US$33.7 million award under the Advanced Research Projects Agency for Health (ARPA-H, an agency within the U.S. Department of Health and Human Services (HHS)) Autonomous Interventions and Robotics (AIR) program, led by Dr. Ileana Hancu, to advance AI-enabled robotic procedure automation for stroke care. Working with Johns Hopkins University, Boston University, and Dr. J Mocco of Weill Cornell Medicine, Philips will develop technologies for remote-assisted and increasingly automated endovascular procedures, helping expand access to advanced stroke care.

Philips selected for ARPA-H program to advance AI-enabled robotic stroke care

Philips prices EU green bond for EUR 650M

August 24, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 650 million fixed rate notes due 2034 (the “Notes”) under its European Medium Term Note (EMTN) program. The Notes are the healthcare industry's first EU Green Bond under the new European Green Bond Standard.

Philips prices EU green bond for EUR 650M

Philips, Shell targeted by hacking group

Philips and Shell were recently targeted by Cl0p, the hacking group said in a statement on its website.

Philips, Shell targeted by hacking group

Agnelli family's Exor can raise Philips stake to 22% under updated agreement

Philips' largest shareholder Exor , the investment arm of Italy's Agnelli family, has extended its agreement with the health ‌technology firm, giving it the flexibility to increase its stake to up to 22%, the companies said on Tuesday.

Agnelli family's Exor can raise Philips stake to 22% under updated agreement

Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside

August 6, 2026 New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home Amsterdam, Netherlands. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare, further expanding its open monitoring ecosystem.

Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside

See News Rankings

Price charts implemented using Lightweight Charts™